1.1Separate first pair circuits
Each chamber draws medium from its own reservoir and returns it to the same reservoir. Independent flow controllers set the chamber flow rates, and a common timing signal synchronizes changes in flow.
Generated automatically. Not reviewed by a person. Not legal advice or an opinion.
Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.
Each chamber draws medium from its own reservoir and returns it to the same reservoir. Independent flow controllers set the chamber flow rates, and a common timing signal synchronizes changes in flow.
Each chamber circulates medium through a dedicated loop. A pipette transfers a measured volume from one loop reservoir to the other, and a return transfer of equal volume restores the original liquid levels.
A clamped roof seals the chamber during perfusion, and the medium exits through a dedicated liquid outlet. After flow stops, the roof lifts away and a removable culture substrate carries the cells out of the chamber.
A controlled gas mixture equilibrates the medium across a free liquid surface in an upstream reservoir. The conditioned medium enters through the liquid inlet, and an optical sensor near the chamber measures dissolved oxygen.
Rotating rollers compress a flexible tube in sequence and displace medium along the loop. A flow sensor downstream of the pump measures the average flow rate for motor speed control.
Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.
Each of the two perfusion loops connects a chamber containing human keratinocytes to a chamber containing human dermal fibroblasts. Each loop has its own recirculation pump, and a shared gas channel runs along the gas-permeable chamber walls. The medium inlet of one loop receives a cosmetic ingredient formulation, and the corresponding inlet of the other loop receives the formulation vehicle. An imaging system records cell morphology through transparent chamber floors.
Two miniature roller peristaltic pumps replace the two on-chip pumps, with one pump assigned to each chamber pair. Flexible tubing connects the downstream medium outlet of each pair to its pump inlet and connects the pump discharge to the upstream medium inlet. An inline pulse dampener between each pump and chamber pair reduces flow oscillations, and an inline flow sensor measures the mean flow used to set pump speed.
Each of the four chambers has a rectangular culture section 12 millimeters long, 4 millimeters wide, and 0.5 millimeters high, with a gas-permeable roof and a flat cell-bearing floor. The medium inlet expands to the full chamber width before the culture section, and the medium outlet contracts downstream of it. Each pump circulates medium through its chamber pair in series at 10, 30, or 60 microliters per minute for successive 20-minute intervals. The uniform culture section sets the cross section used to calculate nominal wall shear from measured flow and medium viscosity.
The four-chamber chip mounts in a motorized inverted microscope stage insert, with a coverslip forming the floor of each chamber. Tubing routes the medium loops and gas feed above the insert, leaving clearance below the chip for the objective. The stage controller stores one imaging position per chamber and cycles through the four positions at fixed intervals while both pumps circulate medium. A stage enclosure maintains the culture temperature during imaging.
A tee at the downstream medium outlet of each chamber pair connects the return line to a valve-controlled sampling branch. At each sampling interval, a syringe autosampler draws a metered aliquot from one branch and dispenses it into a designated well of a microplate. A separate metering syringe adds an equal volume of fresh medium to the corresponding loop reservoir. A microplate reader measures glucose and lactate with colorimetric assays, and the sample record links each well to its loop and collection time.
An inline flow sensor sits between each pump discharge and the medium inlet of the first chamber in its pair. A controller averages each sensor signal over a window spanning several pump cycles and compares the result with the flow setpoint for that loop. A proportional-integral controller adjusts each pump drive independently to hold the corresponding setpoint. The controller records flow and drive settings and flags a sustained low-flow condition when the drive reaches its upper limit.
Each chamber has four drilled ports that connect to separate passages in a rigid manifold. The cell inlet and outlet align with a straight passage across the chamber, and the medium inlet and outlet connect through side passages.
A 50-micrometer silicone film spans the four chamber openings and forms their upper wall. A gasket seals the film around each opening, and ribs in the gas manifold support the film between chambers.
A rigid cover contains a serpentine groove that runs across the membrane above all four chambers. The membrane closes the open face of the groove, and ports at opposite ends admit and exhaust the gas.
A gas-impermeable film covers the gas-facing membrane surface and has one open window above each chamber. Gas enters through the channel inlet and diffuses through the exposed membrane at each window.
Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.
The second well is fluidly connected with the first well with a first perfusion membrane. The first perfusion membrane is disposed in between the well frame and the planar substrate and extends from an outlet section of the second well to an inlet section of the first well.A · US 2015/0004686 A1 · ¶ 183
The fourth well 170 is fluidly connected with the third well 110 with a third perfusion membrane 190. The third perfusion membrane 190 is similar to the first perfusion membrane 130 and the second perfusion membrane 150 except that the third perfusion membrane 190 extends from an outlet section 114 of the third well 110 to an inlet section 172 of the fourth well 170.A · US 2015/0004686 A1 · ¶ 70
FIG. 1 further illustrates a vessel 110 having a plurality of outlets 160, 170. As shown in FIG. 1, outlet 160 may be fluidly connected to a small pore membrane device 200, and outlet 170 may be fluidly connected to a cell harvest line 400.B · US 2020/0332242 A1 · ¶ 35
In a twenty-fifth aspect, the disclosure provides methods of fabricating a microplate according to the twenty-fourth aspect, in which the method includes providing a well frame which defines a plurality of cavities therethrough, positioning at least one perfusion membrane on a bottom surface of the well frame such that each of the at least one perfusion membranes extends from a first cavity of the plurality of cavities to a second cavity of the plurality of cavities, whereinA · US 2015/0004686 A1 · ¶ 207
Optionally, flowing medium from the vessel 110 of the bioreactor system 100 to a membrane device 200, 300 may include pumping the medium from the vessel 110 to an external recirculation loop that is fluidly connected to the vessel 110 where the medium contacts a membrane.B · US 2020/0332242 A1 · ¶ 44
The rocking motion induces waves in the culture media which promote agitation and oxygen transfer within the vessel.B · US 2020/0332242 A1 · ¶ 32
An empty cell means only that no passage was reproduced there.
As a result, the performance of long term cell cultures requires manual medium exchange to provide nutrients to cells and to remove waste; however, such medium exchange may result in the disturbance and removal of healthy cells from wells.A · US 2015/0004686 A1 · ¶ 5
Accordingly, ongoing needs exist for alternative microplate designs for culturing cells with automatic, continuous perfusion of a liquid medium.A · US 2015/0004686 A1 · ¶ 6
The present disclosure generally relates to perfusion bioreactor systems and, more particularly, to perfusion bioreactor systems including assemblies for separating cells from microcarriers and exchanging liquids in the perfusion bioreactor systems.B · US 2020/0332242 A1 · ¶ 2
However, as the microcarriers build up on the screen, they begin to clog the screen and prevent the fluid from passing therethrough.B · US 2020/0332242 A1 · ¶ 4
patent.fyi, US 2026/0357175 A1, claim 1, first published 2026-11-20T11:28:11-05:00, https://patent.fyi/US20260357175/, SHA-256 f7fbbabb595247ef87ce86b94b873e395157412a7eec612ddc8ab82e0ddd9e50